DATA GRAPHICS | Data Byte
Three radiotherapy companies have raised over $200M in 1Q22
March fund-raisings equate to over 80% of 2021’s total venture capital raised and almost two-thirds of 2020’s total
March 29, 2022 12:41 AM UTC
The growing targeted radiotherapy space saw three private biotechs raise venture rounds this month. While the financings were the first disclosed this year for companies focused on radiopharmaceuticals, they put total venture raised by the group at 82% of 2021’s full-year total and 64% of 2020’s total.
The three financings brought in nearly $205 million, while radiotherapeutics developers raised $250 million in venture funding in 2021 and $321 million in 2020, according to BioCentury’s BCIQ database...